Castleark Management LLC Halozyme Therapeutics, Inc. Transaction History

Castleark Management LLC

$2.41 Billion
Q3 2024

A detailed history of Castleark Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 69,720 shares of HALO stock, worth $3.9 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

69,720

Holding current value

$3.9 Million

% of portfolio

0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $3.58 Million - $4.49 Million	69,720 New	69,720 $3.99 Million
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $395,041 - $499,137	-11,856 Reduced 9.28%	115,894 $4.28 Million
Q3 2023 Nov 15, 2023	BUY	$36.46 - $44.03 $4.66 Million - $5.62 Million	127,750 New	127,750 $4.88 Million
Q4 2022 Feb 09, 2023	SELL	$40.06 - $59.44 $443,464 - $658,000	-11,070 Reduced 5.11%	205,680 $11.7 Million
Q3 2022 Nov 15, 2022	BUY	$38.53 - $51.78 $493,569 - $663,301	12,810 Added 6.28%	216,750 $8.57 Million
Q2 2022 Aug 16, 2022	BUY	$37.35 - $48.3 $7.62 Million - $9.85 Million	203,940 New	203,940 $8.97 Million
Q4 2021 Feb 16, 2022	SELL	$31.82 - $40.75 $6.99 Million - $8.96 Million	-219,787 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $3.77 Million - $4.55 Million	-98,000 Reduced 30.84%	219,787 $8.94 Million
Q2 2021 Aug 17, 2021	SELL	$38.84 - $51.31 $4.38 Million - $5.79 Million	-112,815 Reduced 26.2%	317,787 $14.4 Million
Q1 2021 May 14, 2021	SELL	$39.51 - $51.45 $2.71 Million - $3.53 Million	-68,540 Reduced 13.73%	430,602 $18 Million
Q4 2020 Feb 17, 2021	SELL	$25.81 - $43.62 $2.57 Million - $4.34 Million	-99,475 Reduced 16.62%	499,142 $21.3 Million
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $963,499 - $1.11 Million	37,432 Added 6.67%	598,617 $15.7 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $2 Million - $3.31 Million	123,315 Added 28.16%	561,185 $15 Million
Q1 2020 May 13, 2020	BUY	$13.9 - $21.83 $6.09 Million - $9.56 Million	437,870 New	437,870 $7.88 Million
Q3 2018 Nov 15, 2018	SELL	$16.68 - $18.41 $7.06 Million - $7.79 Million	-423,305 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$16.87 - $20.3 $161,597 - $194,453	-9,579 Reduced 2.21%	423,305 $7.14 Million
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $1.41 Million - $1.75 Million	82,529 Added 23.56%	432,884 $8.48 Million
Q4 2017 Feb 15, 2018	BUY	$16.75 - $20.8 $1.97 Million - $2.44 Million	117,450 Added 50.43%	350,355 $7.1 Million
Q3 2017 Nov 15, 2017	BUY	$11.76 - $17.4 $2.74 Million - $4.05 Million	232,905	232,905 $4.05 Million

Others Institutions Holding HALO

# of Institutions

540

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.79B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Account

Castleark Management LLC Halozyme Therapeutics, Inc. Transaction History